The overall goal of Dr. Plon's laboratory is to understand the genetic basis of inherited susceptibility to cancer. At a basic level, they are interested in studying genes that normally control genomic stability and, when disrupted, lead to the instability seen in cancer cells including chromosome losses and gains or aneuploidy. Disruption of these control mechanisms have been found in a large percentage of human tumors and in individuals with a predisposition to specific cancer.
A light lunch will be available at 11:45 outside the room.
Continuing Medical Education Credit
Continuing Medical Education (CME) credit is being offered for the 2017 - 2018 Genetics and Genomics Grand Rounds series through the University of Arizona College of Medicine - Tucson.
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Integrate advances in genetic diagnosis and treatment of the day-to-day practices of research and clinical care of childhood cancer patients.
- Order appropriate diagnostic evaluations for patients at risk for hereditary cancer conditions.
Dr. Plon has disclosed she is a member of the Scientific Advisory Board for Baylor Genetics.
All other Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
The Center for Applied Genetics and Genomic Medicine and the University of Arizona Cancer Center Collaborative Cancer Grand Rounds
Janae Gregston at email@example.com